OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

FDA Approves Giredestrant Plus Everolimus: A New Treatment Option for ESR1-Mutated Advanced Breast Cancer

The Victoria’s Secret Era We Should Be Talking About

Northeast GI Oncology Congress 2026

Sarbajit Mukherjee: New Study Reveals Global and Gender Gaps in Oncology Research Authorship

AmCORE Study: Treatment Patterns and Survival Across Age Groups in Colorectal Liver Metastases

Hana Nimer: Reflections on the GCCA and WPA Congresses in Nairobi – Patient Advocate Events Insights

Rohini Singh Sisodia: The Powerful Difference Between Being Cured and Being Healed

Zainab Shinkafi-Bagudu։ Working to Accelerate WHO Targets For HPV Vaccination, Screening and Treatment by 2030

Radiotherapy

OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.